• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Public Health . Public Health Initiatives From Hospitalized Patients With COVID-19, China

tetano

Editor, Senior Moderator
J Infect Public Health


. 2020 Jun 19;S1876-0341(20)30523-2.
doi: 10.1016/j.jiph.2020.06.013. Online ahead of print.
Public Health Initiatives From Hospitalized Patients With COVID-19, China


Chenkai Zhao[SUP] 1 [/SUP], Yueqin Xu[SUP] 2 [/SUP], Xu Zhang[SUP] 2 [/SUP], Yaping Zhong[SUP] 1 [/SUP], Li Long[SUP] 3 [/SUP], Wenzhi Zhan[SUP] 3 [/SUP], Tingting Xu[SUP] 3 [/SUP], Chen Zhan[SUP] 3 [/SUP], Yuehan Chen[SUP] 3 [/SUP], Jinghai Zhu[SUP] 1 [/SUP], Wei Xiao[SUP] 4 [/SUP], Miao He[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Since December 2019, when it first occurred in Wuhan, China, coronavirus disease 2019 (COVID-19) has spread rapidly worldwide via human-to-human transmission. We aimed to describe the epidemiological and demographic features of COVID-19 outside Wuhan.
Methods: A single-center case series of 136 consecutive (from January 16 to February 17, 2020) patients with confirmed COVID-19 hospitalized in The First People's Hospital of Jingzhou, China, was retrospectively analyzed. Outcomes were followed up until February 19, 2020.
Results: Of the 136 patients (median age, 49 years; interquartile range [IQR], 33-63 years; range, 0.3-83 years), 91 (67%) had been to Wuhan or contacted persons from Wuhan. Forty-five (33.1%) were familial clusters. The median incubation period was 6 days (IQR: 4-11 days). All children had an exact exposure history, family members with COVID-19, and "Mild/Moderate" symptoms at admission. Among the 64 elderly patients, 14 (21.9%) had no exposure history, and 43 (67.2%) had a chronic illness. All 11 (8.1%) "Severe/very severe" illness at onset cases and 5 (3.7%) fatal cases were elderly patients. The duration from symptom onset to admission was positively correlated with the duration from symptom onset to endpoint. Overall, patients with a longer incubation period had more severe outcomes.
Conclusion: As high-risk susceptible groups, strong protection should be implemented for children and the elderly. Universal screening should be performed for people with a clear exposure history, even lacking apparent symptoms. Given the rapid progression of COVID-19, people should be admitted quickly following symptom onset.

Keywords: China; Coronavirus disease 2019; Epidemiology; High-risk susceptible people; Incubation period.
 
Back
Top Bottom